I‐Li Tan

761 total citations
8 papers, 349 citations indexed

About

I‐Li Tan is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, I‐Li Tan has authored 8 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Oncology. Recurrent topics in I‐Li Tan's work include Glioma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (1 paper) and Barrier Structure and Function Studies (1 paper). I‐Li Tan is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (1 paper) and Barrier Structure and Function Studies (1 paper). I‐Li Tan collaborates with scholars based in United States, Canada and Germany. I‐Li Tan's co-authors include Wendy L. See, Russell O. Pieper, Theodore Nicolaides, Joydeep Mukherjee, Travis Zack, Timothy A. Chan, Steven E. Schumacher, Selvaraju Veeriah, Rameen Beroukhim and Yongxing Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and PLoS ONE.

In The Last Decade

I‐Li Tan

8 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I‐Li Tan United States	7	220	80	77	59	59	8	349
Hsiang‐Chih Lu United States	8	142 0.6×	73 0.9×	54 0.7×	60 1.0×	18 0.3×	23	290
Israel Ben‐Dor Israel	8	304 1.4×	63 0.8×	36 0.5×	59 1.0×	36 0.6×	9	472
Melissa M. Fraser United States	7	272 1.2×	169 2.1×	45 0.6×	54 0.9×	56 0.9×	7	464
Qingfang Sun China	10	291 1.3×	49 0.6×	35 0.5×	30 0.5×	139 2.4×	11	395
Luo-an Fu China	12	171 0.8×	86 1.1×	137 1.8×	54 0.9×	106 1.8×	18	427
Huarui Zheng China	8	232 1.1×	117 1.5×	51 0.7×	125 2.1×	104 1.8×	17	501
Chaomei Xiang United States	11	369 1.7×	62 0.8×	31 0.4×	90 1.5×	120 2.0×	15	538
Janet L. Oblinger United States	14	247 1.1×	30 0.4×	112 1.5×	57 1.0×	76 1.3×	21	456
Fangling Cheng China	9	153 0.7×	87 1.1×	20 0.3×	68 1.2×	96 1.6×	18	339
Cecilia Krona Sweden	15	282 1.3×	73 0.9×	29 0.4×	96 1.6×	158 2.7×	21	486

Countries citing papers authored by I‐Li Tan

Since Specialization

Citations

This map shows the geographic impact of I‐Li Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Li Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Li Tan more than expected).

Fields of papers citing papers by I‐Li Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Li Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Li Tan. The network helps show where I‐Li Tan may publish in the future.

Co-authorship network of co-authors of I‐Li Tan

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Li Tan. A scholar is included among the top collaborators of I‐Li Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Li Tan. I‐Li Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tan, I‐Li, Alexendar R. Perez, Rachel J. Lew, et al.. (2023). Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis. Cell Reports. 42(11). 113339–113339. 9 indexed citations

2.

Tan, I‐Li, Raquel Duque do Nascimento Arifa, Harikrishna Rallapalli, et al.. (2020). CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model. Oncogene. 40(2). 396–407. 49 indexed citations

3.

Rallapalli, Harikrishna, I‐Li Tan, Alexandre Wojcinski, et al.. (2019). MEMRI‐based imaging pipeline for guiding preclinical studies in mouse models of sporadic medulloblastoma. Magnetic Resonance in Medicine. 83(1). 214–227. 5 indexed citations

4.

Tan, I‐Li, Alexandre Wojcinski, Harikrishna Rallapalli, et al.. (2018). Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation. Proceedings of the National Academy of Sciences. 115(13). 3392–3397. 23 indexed citations

5.

Tan, I‐Li, Priya Radhakrishnan, Robert A. Hirst, et al.. (2014). RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells. PLoS ONE. 9(1). e86187–e86187. 25 indexed citations

6.

Gong, Yongxing, Travis Zack, Luc G.T. Morris, et al.. (2014). Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nature Genetics. 46(6). 588–594. 134 indexed citations

7.

Kaur, Gurvinder, Joseph M. Kim, Rajwant Kaur, et al.. (2013). G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells. Journal of Clinical Neuroscience. 20(7). 1014–1018. 25 indexed citations

8.

See, Wendy L., I‐Li Tan, Joydeep Mukherjee, Theodore Nicolaides, & Russell O. Pieper. (2012). Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency. Cancer Research. 72(13). 3350–3359. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact